Europe Peritoneal Dialysis Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Market Overview
The Europe Peritoneal Dialysis Market is expected to expand from USD 2,499.93 million in 2023 to USD 3,829.10 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.15% over the forecast period.

Market expansion is primarily driven by the rising incidence of end-stage renal disease (ESRD) and an aging demographic increasingly prone to chronic kidney disorders. Advances in dialysis technologies and solutions, along with growing awareness of home-based care options, are further supporting market momentum. Favorable reimbursement frameworks and government-led initiatives promoting peritoneal dialysis as a cost-efficient alternative to hemodialysis have also enhanced adoption rates. Notable trends include the evolution of automated peritoneal dialysis (APD) systems that improve patient adherence and convenience, and the introduction of biocompatible dialysis solutions designed to reduce treatment-related complications. Additionally, the integration of telemedicine and remote monitoring tools into dialysis care reflects a broader shift toward personalized and efficient treatment management. Together, these developments create a dynamic and innovation-driven landscape, fostering broader utilization of peritoneal dialysis across the European market.

Market Drivers
Rising Preference for Home-Based Care

The growing inclination toward home-based medical treatment models is a key driver in the peritoneal dialysis market. This method allows patients to manage dialysis in a more flexible, independent manner, reducing hospital dependency and enhancing overall quality of life. It also aligns with the healthcare sector’s shift toward patient-centric and cost-effective care delivery. According to the Global Kidney Health Atlas 2023, 21 individuals per million population initiate chronic peritoneal dialysis annually in Western Europe, signaling increased acceptance of home-based modalities. Supporting this trend are innovations in portable and user-friendly dialysis devices, which facilitate safe and manageable in-home treatment.

Market Challenges Analysis
Low Awareness and Prevailing Misconceptions

A significant obstacle to broader adoption of peritoneal dialysis in Europe is the general lack of awareness and persistent misconceptions among patients. Many are unfamiliar with the benefits of peritoneal dialysis, including its suitability for home care and the increased lifestyle flexibility it offers compared to conventional hemodialysis. Misunderstandings regarding the complexity of self-administration and concerns over infection risks further deter usage. For instance, findings from the European Renal Association show that only 13% of renal replacement therapy patients utilize peritoneal dialysis, highlighting limited knowledge and acceptance. These challenges underscore the need for targeted awareness initiatives and improved communication between healthcare professionals and patients to encourage informed decision-making.

Market Segmentation

By Type:

Continuous Ambulatory Peritoneal Dialysis (CAPD)

Automated Peritoneal Dialysis (APD)

By Product:

Peritoneal Dialysis Machines

Peritoneal Dialysis Solutions

Dialysis Catheters

Others

By End-user:

Hospitals

Dialysis Centers

Home Care Settings

By Geography:

United Kingdom

France

Germany

Italy

Spain

Russia

Belgium

Netherlands

Austria

Sweden

Poland

Denmark

Switzerland

Rest of Europe

Key Player Analysis

Fresenius Medical Care AG & Co. KGaA

B. Braun Melsungen AG

Nipro Corporation

Baxter International Inc.

Medtronic plc

Diaverum AB

Gambro (Fresenius Medical Care)

Vifor Pharma

Nikkiso Europe GmbH

Hemotech